New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 4, 2013
15:34 EDTMDXGMiMedx to reiterate request for meeting with FDA
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
07:25 EDTMDXGMiMedx developing into regenerative medicine play, says Canaccord
Canaccord believes MiMedx is developing a platform technology based regenerative medicine company leveraging its amniotic tissue technology. The firm sees the ground work being laid via distribution and clinical data that will drive growth in 2016 and beyond. Canaccord reiterated its Buy rating and $14 price target on MiMedx shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use